Detalles de la búsqueda
1.
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
BMC Cancer
; 24(1): 321, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454345
2.
Single Nucleotide Polymorphisms in MicroRNA-Binding Site of Epidermal Growth Factor Receptor Signaling Pathway and Susceptibility to Esophageal Squamous Cell Carcinoma.
Dig Dis
; 38(1): 1-8, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31269493
3.
Association of single nucleotide polymorphisms in ERCC2 gene and their haplotypes with esophageal squamous cell carcinoma.
Tumour Biol
; 35(5): 4225-31, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390613
4.
Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
Oncotarget
; 10(40): 4069-4078, 2019 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31258850
5.
With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis.
Radiother Oncol
; 129(1): 154-160, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29122362
6.
Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
Oncotarget
; 13: 1300, 2022 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473119
7.
Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies.
Asian Pac J Cancer Prev
; 14(4): 2337-42, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23725137
Resultados
1 -
7
de 7
1
Próxima >
>>